WHO ICTRP trial
The effect of oxytocin in the treatment of methadone maintenance patients
IRCT20231101059923N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20231101059923N1 |
|---|---|
| Public title | The effect of oxytocin in the treatment of methadone maintenance patients |
| Scientific title | The effect of oxytocin on craving, sleep quality, sexual and thyroid disorders, and the expression of genes involved in drug craving in patients under methadone maintenance treatment |
| Primary sponsor | Kashan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Addiction. Other psychoactive substance related disorders |
| Interventions | Intervention 1: Intervention group: Oxytocin 40 IU is administered intranasally, once a day for four weeks. Oxytocin spray contains oxytocin powder (Aburaihan Pharmaceutical Company), sterile normal saline, and 50% ethanol. Intervention 2… |
| Registration date | Dec 4, 2023 |
| Target size | 66 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: